Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Review Article
Authors: Fernando, Warnakulasuriya M.A.D.B.a; 1 | Somaratne, Geeshanic; d; 1 | Goozee, Kathryn G.a; b; f; g; h; i | Williams, Shehane | Singh, Harjinderc; d | Martins, Ralph N.a; b; f; g; h; i; *
Affiliations: [a] Centre of Excellence in Alzheimer’s Disease Research and Care, School of Medical Sciences, Edith Cowan University, Joondalup, Australia | [b] School of Biomedical Science, Macquarie University, Sydney, NSW, Australia | [c] Massey Institute of Food Science and Technology, Massey University, Palmerston North, New Zealand | [d] Riddet Institute, Massey University, Palmerston North, New Zealand | [e] Faculty of Medicine, University of Kelaniya, Colombo, Sri Lanka | [f] KARVIAH Research Centre, Anglicare, Castle Hill, NSW, Australia | [g] School of Psychiatry and Clinical Neurosciences, The University of Western Australia, Nedlands, WA, Australia | [h] Department of Biomedical Sciences, Macquarie University, Sydney, NSW, Australia | [i] KaRa Institute of Neurological Diseases, Sydney, NSW, Australia
Correspondence: [*] Correspondence to: Professor R.N. Martins, Centre of Excellence in Alzheimer’s Disease Research and Care, School of Medical Sciences, Edith Cowan University, Joondalup,Australia. Tel.: +61 8 6304 5456; Fax: +61 8 93474299; E-mail: [email protected].
Note: [1] These authors contributed equally to this work.
Abstract: Dementia and diabetes mellitus are prevalent disorders in the elderly population. While recognized as two distinct diseases, diabetes has more recently recognized as a significant contributor to risk for developing dementia, and some studies make reference to type 3 diabetes, a condition resulting from insulin resistance in the brain. Alzheimer’s disease, the most common form of dementia, and diabetes, interestingly, share underlying pathological processes, commonality in risk factors, and, importantly, pathways for intervention. Tea has been suggested to possess potent antioxidant properties. It is rich in phytochemicals including, flavonoids, tannins, caffeine, polyphenols, boheic acid, theophylline, theobromine, anthocyanins, gallic acid, and finally epigallocatechin-3-gallate, which is considered to be the most potent active ingredient. Flavonoid phytochemicals, known as catechins, within tea offer potential benefits for reducing the risk of diabetes and Alzheimer’s disease by targeting common risk factors, including obesity, hyperlipidemia, hypertension, cardiovascular disease, and stroke. Studies also show that catechins may prevent the formation of amyloid-β plaques and enhance cognitive functions, and thus may be useful in treating patients who have Alzheimer’s disease or dementia. Furthermore, other phytochemicals found within tea offer important antioxidant properties along with innate properties capable of modulating intracellular neuronal signal transduction pathways and mitochondrial function.
Keywords: Alzheimer’s disease, cognitive impairment, diabetes, phytochemicals, tea
DOI: 10.3233/JAD-161200
Journal: Journal of Alzheimer's Disease, vol. 59, no. 2, pp. 481-501, 2017
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]